title: Public biotechnology 2005--the numbers.
abstract: Although investors remained cautious of public biotech companies in 2005, acquisitions and research partnerships were on the up.
authors.forename: Riku
authors.initials: R
authors.lastname: Lähteenmäki
authors.forename: Stacy
authors.initials: S
authors.lastname: Lawrence
mesh_terms: D001709:Biotechnology / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D005060:Europe; D007182:Income / Q000706:statistics & numerical data* / Q000639:trends; D007221:Industry / Q000191:economics* / Q000706:statistics & numerical data* / Q000639:trends; D017150:Public Sector / Q000191:economics* / Q000706:statistics & numerical data*; D014481:United States